Sun Pharma to acquire Organon for $11.75B in innovative shift
Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Organon in an all-cash transaction valued at $11.75 billion, a move that propels the Indian multinational into the top tier of global pharmaceutical players and secures a leading position in the women’s health sector.
-640x360.webp&w=3840&q=75)






















